UNCY

Unicycive Therapeutics, Inc. - Common Stock (UNCY)

About Unicycive Therapeutics, Inc. - Common Stock (UNCY)

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Details

Daily high

$6.37

Daily low

$4.84

Price at open

$6.25

52 Week High

$11.00

52 Week Low

$2.02

Market cap

75.9M

Dividend yield

0.00%

Volume

2.4M

Avg. volume

954,865

P/E ratio

-3.09

Unicycive Therapeutics, Inc. - Common Stock News